<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0049">
 <label>49</label>
 <element-citation publication-type="journal" id="sbref0046">
  <person-group person-group-type="author">
   <name>
    <surname>Kreil</surname>
    <given-names>T.R.</given-names>
   </name>
   <name>
    <surname>Mc Vey</surname>
    <given-names>J.K.</given-names>
   </name>
   <name>
    <surname>Lei</surname>
    <given-names>L.S.</given-names>
   </name>
   <name>
    <surname>Camacho</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Wodal</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Kerschbaum</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>Preparation of commercial quantities of a hyperimmune human intravenous immunoglobulin preparation against an emerging infectious disease: the example of pandemic H1N1 influenza</article-title>
  <source>Transfusion</source>
  <volume>52</volume>
  <year>2012</year>
  <fpage>803</fpage>
  <lpage>809</lpage>
  <pub-id pub-id-type="doi">10.1111/j.1537-2995.2011.03347.x</pub-id>
  <pub-id pub-id-type="pmid">21981280</pub-id>
 </element-citation>
</ref>
